Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery

Annals of Vascular Surgery

Volumn 27, Issue 4, 2013, Pages 537-545

  Lau, Wei C ^a   Froehlich, James B ^a   Jewell, Elizabeth S ^a   Montgomery, Daniel G ^a   Eng, Kristina M ^a   Shields, Theresa A ^a   Henke, Peter K ^a   Eagle, Kim A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG EFFICACY; ELECTIVE SURGERY; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; LUNG DISEASE; MAJOR SURGERY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MICHIGAN; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 84876683267     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2012.12.001     Document Type: Article

References (36)

1. L.A. Fleisher, J.A. Beckman, and K.A. Brown ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery Circulation 116 2007 e418 e499
2. D. Poldermans, J.J. Bax, and M.D. Kertai Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
3. E. Boersma, D. Poldermans, and J.J. Bax Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy JAMA 285 2001 1865 1873
4. N.R. Hertzer, E.G. Beven, and J.R. Young Coronary artery disease in peripheral vascular patients. A classification of 1,000 coronary angiograms and results of surgical management Ann Surg 199 1984 223 233
5. M.M. Dawood, D.K. Gutpa, J. Southern, A. Walia, J.B. Atkinson, and K.A. Eagle Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention Int J Cardiol 57 1996 37 44
6. K. Takenaka, E. Ogawa, H. Wada, and T. Hirata Systemic inflammatory response syndrome and surgical stress in thoracic surgery J Crit Care 21 2006 48 53
7. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
8. M.D. Kertai, J. Klein, J.J. Bax, and D. Poldermans Predicting perioperative cardiac risk Progr Cardiovasc Dis 47 2005 240 257
9. L.A. Fleisher, J.A. Beckman, and K.A. Brown 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 e169 e276
10. M.D. Kertai, E. Boersma, and C.M. Westerhout A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery Eur J Vasc Endovasc Surg 28 2004 343 352
11. H.H. Feringa, V.H. van Waning, and J.J. Bax Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease J Am Coll Cardiol 47 2006 1182 1187
12. H.H. Feringa, J.J. Bax, and S.E. Karagiannis Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction Arch Gerontol Geriatr 48 2009 116 120
13. D.C. Warltier, P.S. Pagel, and J.R. Kersten Approaches to the prevention of perioperative myocardial ischemia Anesthesiology 92 2000 253 259
14. T. Ohtsuka, M. Hamada, and G. Hiasa Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy J Am Coll Cardiol 37 2001 412 417
15. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
16. T.H. Lee, E.R. Marcantonio, and C.M. Mangione Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circulation 100 1999 1043 1049
17. E. Boersma, M.D. Kertai, and O. Schouten Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index Am J Med 118 2005 1134 1141
18. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
19. S. Lemeshow, and D.W. Hosmer Jr. A review of goodness of fit statistics for use in the development of logistic regression models Am J Epidemiol 115 1982 92 106
20. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
21. D. Poldermans, O. Schouten, and R. Vidakovic A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study J Am Coll Cardiol 49 2007 1763 1769
22. S. Urbonavicius, H. Vorum, G. Urbonaviciene, M. Trumpickas, D. Pavalkis, and B. Honore Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm Curr Control Trials Cardiovasc Med 6 2005 14
23. D.T. Mangano, W.S. Browner, M. Hollenberg, M.J. London, J.F. Tubau, and I.M. Tateo Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery N Engl J Med 323 1990 1781 1788
24. D. Poldermans, E. Boersma, and J.J. Bax Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery Eur Heart J 22 2001 1353 1358
25. J.M. Cruickshank Beta-blockers continue to surprise us Eur Heart J 21 2000 354 364
26. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 2008 1839 1847
27. D. Poldermans, E. Boersma, and J.J. Bax The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery N Engl J Med 341 1999 1789 1794
28. M. Dunkelgrun, E. Boersma, and O. Schouten Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV) Ann Surg 249 2009 921 926
29. O. Schouten, E. Boersma, and S.E. Hoeks Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 361 2009 980 989
30. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
31. D.L. Bhatt Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention Am J Cardiol 101 2008 4D 13D
32. D.L. Bhatt, and E.J. Topol Scientific and therapeutic advances in antiplatelet therapy Nat Rev Drug Discov 2 2003 15 28
33. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
34. E.M. Lonn, S. Yusuf, and P. Jha Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection Circulation 90 1994 2056 2069
35. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
36. J. Ostergren, P. Sleight, and G. Dagenais Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease Eur Heart J 25 2004 17 24